Altenbuchinger, Michael

[["dc.bibliographiccitation.firstpage","3596"],["dc.bibliographiccitation.issue","10"],["dc.bibliographiccitation.journal","Journal of Proteome Research"],["dc.bibliographiccitation.lastpage","3605"],["dc.bibliographiccitation.volume","16"],["dc.contributor.author","Zacharias, Helena U."],["dc.contributor.author","Rehberg, Thorsten"],["dc.contributor.author","Mehrl, Sebastian"],["dc.contributor.author","Richtmann, Daniel"],["dc.contributor.author","Wettig, Tilo"],["dc.contributor.author","Oefner, Peter J."],["dc.contributor.author","Spang, Rainer"],["dc.contributor.author","Gronwald, Wolfram"],["dc.contributor.author","Altenbuchinger, Michael"],["dc.date.accessioned","2021-09-17T09:47:02Z"],["dc.date.available","2021-09-17T09:47:02Z"],["dc.date.issued","2017"],["dc.description.abstract","Metabolomics data is typically scaled to a common reference like a constant volume of body fluid, a constant creatinine level, or a constant area under the spectrum. Such scaling of the data, however, may affect the selection of biomarkers and the biological interpretation of results in unforeseen ways. Here, we studied how both the outcome of hypothesis tests for differential metabolite concentration and the screening for multivariate metabolite signatures are affected by the choice of scale. To overcome this problem for metabolite signatures and to establish a scale-invariant biomarker discovery algorithm, we extended linear zero-sum regression to the logistic regression framework and showed in two applications to 1H NMR-based metabolomics data how this approach overcomes the scaling problem. Logistic zero-sum regression is available as an R package as well as a high-performance computing implementation that can be downloaded at https://github.com/rehbergT/zeroSum ."],["dc.identifier.arxiv","1703.07724v1"],["dc.identifier.doi","10.1021/acs.jproteome.7b00325"],["dc.identifier.pmid","28825821"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/89638"],["dc.language.iso","en"],["dc.relation.eissn","1535-3907"],["dc.relation.issn","1535-3893"],["dc.title","Scale-Invariant Biomarker Discovery in Urine and Plasma Metabolite Fingerprints"],["dc.type","journal_article"],["dc.type.internalPublication","no"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1796"],["dc.bibliographiccitation.issue","4"],["dc.bibliographiccitation.journal","Journal of Proteome Research"],["dc.bibliographiccitation.lastpage","1805"],["dc.bibliographiccitation.volume","18"],["dc.contributor.author","Zacharias, Helena U."],["dc.contributor.author","Altenbuchinger, Michael"],["dc.contributor.author","Schultheiss, Ulla T."],["dc.contributor.author","Samol, Claudia"],["dc.contributor.author","Kotsis, Fruzsina"],["dc.contributor.author","Poguntke, Inga"],["dc.contributor.author","Sekula, Peggy"],["dc.contributor.author","Krumsiek, Jan"],["dc.contributor.author","Köttgen, Anna"],["dc.contributor.author","Spang, Rainer"],["dc.contributor.author","Oefner, Peter J."],["dc.contributor.author","Gronwald, Wolfram"],["dc.date.accessioned","2021-09-17T09:47:06Z"],["dc.date.available","2021-09-17T09:47:06Z"],["dc.date.issued","2019"],["dc.description.abstract","Identification of chronic kidney disease patients at risk of progressing to end-stage renal disease (ESRD) is essential for treatment decision-making and clinical trial design. Here, we explored whether proton nuclear magnetic resonance (NMR) spectroscopy of blood plasma improves the currently best performing kidney failure risk equation, the so-called Tangri score. Our study cohort comprised 4640 participants from the German Chronic Kidney Disease (GCKD) study, of whom 185 (3.99%) progressed over a mean observation time of 3.70 ± 0.88 years to ESRD requiring either dialysis or transplantation. The original four-variable Tangri risk equation yielded a C statistic of 0.863 (95% CI, 0.831-0.900). Upon inclusion of NMR features by state-of-the-art machine learning methods, the C statistic improved to 0.875 (95% CI, 0.850-0.911), thereby outperforming the Tangri score in 94 out of 100 subsampling rounds. Of the 24 NMR features included in the model, creatinine, high-density lipoprotein, valine, acetyl groups of glycoproteins, and Ca2+-EDTA carried the highest weights. In conclusion, proton NMR-based plasma fingerprinting improved markedly the detection of patients at risk of developing ESRD, thus enabling enhanced patient treatment."],["dc.identifier.doi","10.1021/acs.jproteome.8b00983"],["dc.identifier.pmid","30817158"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/89639"],["dc.language.iso","en"],["dc.relation.eissn","1535-3907"],["dc.relation.issn","1535-3893"],["dc.title","A Novel Metabolic Signature To Predict the Requirement of Dialysis or Renal Transplantation in Patients with Chronic Kidney Disease"],["dc.type","journal_article"],["dc.type.internalPublication","no"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","13954"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Scientific Reports"],["dc.bibliographiccitation.volume","9"],["dc.contributor.author","Altenbuchinger, Michael"],["dc.contributor.author","Zacharias, Helena U."],["dc.contributor.author","Solbrig, Stefan"],["dc.contributor.author","Schäfer, Andreas"],["dc.contributor.author","Büyüközkan, Mustafa"],["dc.contributor.author","Schultheiß, Ulla T."],["dc.contributor.author","Kotsis, Fruzsina"],["dc.contributor.author","Köttgen, Anna"],["dc.contributor.author","Spang, Rainer"],["dc.contributor.author","Oefner, Peter J."],["dc.contributor.author","Krumsiek, Jan"],["dc.contributor.author","Gronwald, Wolfram"],["dc.date.accessioned","2021-09-17T09:47:11Z"],["dc.date.available","2021-09-17T09:47:11Z"],["dc.date.issued","2019"],["dc.description.abstract","Omics data facilitate the gain of novel insights into the pathophysiology of diseases and, consequently, their diagnosis, treatment, and prevention. To this end, omics data are integrated with other data types, e.g., clinical, phenotypic, and demographic parameters of categorical or continuous nature. We exemplify this data integration issue for a chronic kidney disease (CKD) study, comprising complex clinical, demographic, and one-dimensional 1H nuclear magnetic resonance metabolic variables. Routine analysis screens for associations of single metabolic features with clinical parameters while accounting for confounders typically chosen by expert knowledge. This knowledge can be incomplete or unavailable. We introduce a framework for data integration that intrinsically adjusts for confounding variables. We give its mathematical and algorithmic foundation, provide a state-of-the-art implementation, and evaluate its performance by sanity checks and predictive performance assessment on independent test data. Particularly, we show that discovered associations remain significant after variable adjustment based on expert knowledge. In contrast, we illustrate that associations discovered in routine univariate screening approaches can be biased by incorrect or incomplete expert knowledge. Our data integration approach reveals important associations between CKD comorbidities and metabolites, including novel associations of the plasma metabolite trimethylamine-N-oxide with cardiac arrhythmia and infarction in CKD stage 3 patients."],["dc.identifier.doi","10.1038/s41598-019-50346-2"],["dc.identifier.pmid","31562371"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/89640"],["dc.language.iso","en"],["dc.relation.issn","2045-2322"],["dc.title","A multi-source data integration approach reveals novel associations between metabolites and renal outcomes in the German Chronic Kidney Disease study"],["dc.type","journal_article"],["dc.type.internalPublication","no"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","47"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Metabolites"],["dc.bibliographiccitation.volume","8"],["dc.contributor.author","Zacharias, Helena U."],["dc.contributor.author","Altenbuchinger, Michael"],["dc.contributor.author","Gronwald, Wolfram"],["dc.date.accessioned","2021-09-17T09:48:09Z"],["dc.date.available","2021-09-17T09:48:09Z"],["dc.date.issued","2018-08-28"],["dc.description.abstract","In this review, we summarize established and recent bioinformatic and statistical methods for the analysis of NMR-based metabolomics. Data analysis of NMR metabolic fingerprints exhibits several challenges, including unwanted biases, high dimensionality, and typically low sample numbers. Common analysis tasks comprise the identification of differential metabolites and the classification of specimens. However, analysis results strongly depend on the preprocessing of the data, and there is no consensus yet on how to remove unwanted biases and experimental variance prior to statistical analysis. Here, we first review established and new preprocessing protocols and illustrate their pros and cons, including different data normalizations and transformations. Second, we give a brief overview of state-of-the-art statistical analysis in NMR-based metabolomics. Finally, we discuss a recent development in statistical data analysis, where data normalization becomes obsolete. This method, called zero-sum regression, builds metabolite signatures whose estimation as well as predictions are independent of prior normalization."],["dc.identifier.doi","10.3390/metabo8030047"],["dc.identifier.pmid","30154338"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/89652"],["dc.language.iso","en"],["dc.relation.issn","2218-1989"],["dc.title","Statistical Analysis of NMR Metabolic Fingerprints: Established Methods and Recent Advances"],["dc.type","journal_article"],["dc.type.internalPublication","no"],["dc.type.subtype","original_ja"],["dspace.entity.type","Publication"]]